Events2Join

AbCellera to Report Second Quarter 2024 Financial Results on ...


AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference ...

AbCellera Reports Q2 2024 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release ...

AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and ...

Q2 2024 Earnings Results and Business Update

We use cookies on investors.abcellera.com to provide you with the best possible experience. If you wish to review the cookies we store, please select the Cookie ...

AbCellera Reports Q2 2024 Business Results - Yahoo Finance

AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported in US ...

Quarterly Results - AbCellera Biologics Inc. - Financials

Q2 Earnings. Webcast(opens in new window) · Presentation(opens in new window) ... Innovation. © 2024 AbCellera Biologics Inc. - All rights reserved. Team.

AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 pm ...

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue ...

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.15.

AbCellera Reports Q2 2024 Business Results | ABCL Stock News

AbCellera (Nasdaq: ABCL) announced its financial results for Q2 2024. Revenue decreased to $7.3 million from $10.1 million in Q2 2023, ...

AbCellera Biologics Second Quarter 2024 Earnings: EPS Beats ...

AbCellera Biologics ( NASDAQ:ABCL ) Second Quarter 2024 Results Key Financial Results Revenue: US$7.32m (down 27% from...

AbCellera on X: "AbCellera to Report Second Quarter 2024 ...

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 https://t.co/F4QZ15NvYj.

News Releases - AbCellera Biologics Inc. - Investor Relations

News Releases ; November 07, 2024. AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 ; November 04, 2024. AbCellera Reports Q3 2024 ...

AbCellera to Report Second Quarter 2024 Financial Results on ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, ...

Logo - AbCellera to Report Second Quarter 2024 Financial Results ...

The global leader in press release distribution and regulatory disclosure. Public relations and investor relations professionals rely on Business Wire for ...

AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time ...

Abcellera Biologics Inc.: AbCellera to Report Second Quarter 2024 ...

25/06/2024 - Abcellera Biologics Inc.: AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024. [X]. Abcellera Biologics Inc. The text ...

AbCellera to Report Third Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024.

Quarterly Results - Investor Relations - Prelude Therapeutics

Form 10-Q. Q2. Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update ... AbCellera, and Reports Third Quarter Financial ...

AbCellera to Report Third Quarter 2024 Financial Results on ...

VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, ...

Abcellera Biologics Inc. (ABCL) - 10-Q Quarterly Report ... - Last10K

VANCOUVER, British Columbia - AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. · “This quarter, we made ...